RCMI Coordinating Center (RCMI CC) Header Logo

Connection

James Chambers to Anticarcinogenic Agents

Back to Details
This is a "connection" page, showing publications James Chambers has written about Anticarcinogenic Agents.
James Chambers
Connection Strength
0.343
Anticarcinogenic Agents
  1. Iida M, Desamero MJ, Yasuda K, Nakashima A, Suzuki K, Chambers JK, Uchida K, Ogawa R, Hachimura S, Nakayama J, Kyuwa S, Miura K, Kakuta S, Hirayama K. Effects of orally administered Euglena gracilis and its reserve polysaccharide, paramylon, on gastric dysplasia in A4gnt knockout mice. Sci Rep. 2021 07 01; 11(1):13640.
    View in: PubMed
    Score: 0.190
  2. Desamero MJ, Kakuta S, Chambers JK, Uchida K, Hachimura S, Takamoto M, Nakayama J, Nakayama H, Kyuwa S. Orally administered brown seaweed-derived ?-glucan effectively restrained development of gastric dysplasia in A4gnt KO mice that spontaneously develop gastric adenocarcinoma. Int Immunopharmacol. 2018 Jul; 60:211-220.
    View in: PubMed
    Score: 0.153
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support